About Amanda

Amanda's practice focuses on advising public and private clients on domestic and cross-border transactions, including mergers & acquisitions, tax-free reorganizations, and debt and equity financings. Amanda regularly advises life sciences clients on the tax aspects of licensing, collaboration, acquisitions, divestitures and profit-sharing arrangements. 

View full bio

Passions

Health, spending time with family, crossfit

Experience

Shoulder Innovations Announces $75 Million IPO

Shoulder Innovations Announces $75 Million IPO

July 31, 2025

Cooley advised the underwriters of Shoulder Innovations, a medical technology company exclusively focused on transforming the shoulder surgical care market, in connection with Shoulder Innovations’ $75 million initial public offering (IPO).

Read more

Related contacts

Denny Won
Partner, San Francisco
Charlie Kim
Partner, San Diego
Kristin VanderPas
Partner, San Francisco
David Peinsipp
Partner, San Francisco
Xander Lee
Partner, Santa Monica
Barbara Mirza
Partner, Santa Monica
Phil Mitchell
Partner, New York
Scott Weston
Partner, Boston
Kassity L. Mai
Special Counsel, Reston
Randy Sabett
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Valerie Sapozhnikova
Associate, Los Angeles
Alex Hammer
Associate, San Francisco
Allison Kutner
Associate, New York
Sunny J. Levine
Associate, Colorado
Ryan Lewis
Associate, Colorado
Sarah Miller
Associate, New York
Marjorie O'Neill
Associate, San Francisco
Amanda Pacheco
Associate, Palo Alto

Related Practices & Industries

Capital Markets
Medtech
Life Sciences
Healthcare
Cyber/Data/Privacy
Patent Counseling and Prosecution
Life Sciences and Healthcare Regulatory
Tax
Compensation and Benefits
CFIUS
CooleyREG

Blue Owl Capital Extends up to $500 Million in Senior Secured Credit to Madrigal Pharmaceuticals

Blue Owl Capital Extends up to $500 Million in Senior Secured Credit to Madrigal Pharmaceuticals

July 21, 2025

Cooley advised Blue Owl (NYSE: OWL), a leading asset manager redefining alternatives, on an up to $500 million term loan facility for Madrigal Pharmaceuticals (NASDAQ: MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis.

Read more

Related contacts

Michael Tollini
Partner, Washington, DC
Addison Pierce
Partner, Chicago
Dr. Jon Cousin
Partner, Washington, DC
Geoffrey Spolyar
Partner, Boston
Xander Lee
Partner, Santa Monica
Phil Mitchell
Partner, New York
Steve Flores
Partner, Chicago
Michael Neumeister
Partner, Los Angeles
Randy Sabett
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Wyatt Kernell
Associate, Colorado
Dr. Asako Kubota
Associate, Washington, DC
Allison Kutner
Associate, New York
Amanda Pacheco
Associate, Palo Alto
Charles A. Watkins II
Associate, Santa Monica
Jeffery Wyzykowski
Patent Agent, Washington, DC
Margie Murphy
Paralegal Specialist, New York

Related Practices & Industries

Debt Finance
Patent Counseling and Prosecution
Life Sciences
Tax
Life Sciences and Healthcare Regulatory
Healthcare
Capital Markets
Compensation and Benefits
Trademark, Copyright and Advertising
Cyber/Data/Privacy
Business Restructuring
CFIUS

Movable Ink to Be Acquired by STG

Movable Ink to Be Acquired by STG

June 26, 2025

Cooley advised Movable Ink, an artificial intelligence-powered personalized content platform, on its definitive agreement to be acquired by STG. The transaction is expected to close in July 2025.

Read more

Related contacts

Adam Dinow
Partner, New York
Bill Sorabella
Partner, New York
Bill Roegge
Partner, New York
Nathan Baum
Special Counsel, New York
Robert Warshaw
Associate, New York
Kyle Hess
Associate, New York
Ethan Ebert-Zavos
Associate, New York
Patrick Flanagan
Partner, New York
Len Jacoby
Partner, New York
Eileen Marshall
Partner, Washington, DC
Kristen Mathews
Partner, New York
Jeremy Morrison
Partner, Washington, DC
John Paul Oleksiuk
Partner, New York
Nyron J. Persaud
Partner, New York
Scott Talbot
Senior Counsel, Reston
Julia R. Brinton
Special Counsel, Washington, DC
David Hopkins
Special Counsel, Colorado
Andrew Linch
Special Counsel, London
Michael Bruno
Associate, New York
Amanda Gonzalez Burton
Associate, New York
Tony P. Guan
Associate, Santa Monica
Nathaniel Hearn Jr.
Associate, Chicago
Bomin Kim
Associate, New York
Richard Koch
Associate, Washington, DC
Allison Kutner
Associate, New York
Alexandra Leavy
Associate, New York
Amanda Pacheco
Associate, Palo Alto
Rubin Waranch
Associate, Colorado
Colleen R. Wellington-Caban
Associate, Washington, DC
Andy Zachrich
Associate, San Francisco
Patricia Myers
Paralegal Specialist, Colorado
Jill Simon
Senior Paralegal, New York
Kevin Gurley
Quantitative Analyst, New York

Related Practices & Industries

Mergers and Acquisitions
Emerging Companies
Artificial Intelligence
Technology
Technology Transactions
Compensation and Benefits
Trademark, Copyright and Advertising
Tax
Cyber/Data/Privacy
Patent Counseling and Prosecution
Labor and Employment
Debt Finance
Antitrust and Competition

Otsuka Pharmaceutical Announces Global Strategic Collaboration With Harbour BioMed

Otsuka Pharmaceutical Announces Global Strategic Collaboration With Harbour BioMed

June 23, 2025

Cooley advised Otsuka Pharmaceutical, a total healthcare company focused on each individual’s potential to enhance their well-being, on its global strategic collaboration with Harbour BioMed to advance BCMAxCD3 bispecific T-cell engagers for treating autoimmune diseases.

Read more

Related contacts

Jennifer Raab
Partner, Palo Alto
Alison Freeman-Gleason
Of Counsel, Seattle
Rachel Thorn
Of counsel, New York
Zack Gong
Associate, Shanghai
Freddy Yip
Associate, Hong Kong
Jonathan Kaufman
Associate, Palo Alto
Natasha Leskovsek
Of Counsel, Washington, DC
Robert Eisenbach
Of Counsel, San Francisco
Amanda Pacheco
Associate, Palo Alto

Related Practices & Industries

Life Sciences Corporate Partnering and Licensing
Life Sciences and Healthcare Regulatory
Business Restructuring
Tax
Biotechnology
Healthcare
Life Sciences
Intellectual Property Litigation

Philochem AG Announces up to $1.35 Billion License Agreement With RayzeBio

Philochem AG Announces up to $1.35 Billion License Agreement With RayzeBio

June 10, 2025

Cooley advised Philochem AG, a wholly owned subsidiary of the Philogen Group (Milan Stock Exchange: PHIL), on its definitive license agreement with RayzeBio, a wholly owned subsidiary of Bristol Myers Squibb (NYSE: BMY), granting RayzeBio exclusive worldwide rights to develop, manufacture and commercialize OncoACP3, a clinical-stage therapeutic and diagnostic agent targeting prostate cancer.

Read more

Related contacts

Kenneth Krisko
Partner, Reston
Joe Sandys
Special Counsel, London
Alexandra Paterson
Associate, London
Joseph Perry
Associate, Reston
J. Brian Stalter
Special Counsel, New York
Aaron Pomeroy
Partner, Colorado
Amanda Pacheco
Associate, Palo Alto
David Burns
Special Counsel, Washington, DC
Megan Browdie
Partner, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Ann Bevitt
Partner, London
Rachel Thorn
Of counsel, New York
Dr. Jon Cousin
Partner, Washington, DC

Related Practices & Industries

Life Sciences Corporate Partnering and Licensing
Healthcare
Biotechnology
Antitrust and Competition
Tax
Life Sciences and Healthcare Regulatory
CooleyREG
Post Acquisition Disputes and Advisory
Cyber/Data/Privacy
View more

Admissions and credentials

California

Memberships and affiliations

American Bar Association - Section of Taxation

Hispanic National Bar Association (HNBA)

State Bar of California, Taxation Section